Overview
- 185 inspections across 168 sites are on record.
- 768 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-04.
At a glance
Inspections
185
Sites
168
Observations
768
Career since
May 2010
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| QuVa Pharma, Inc. | 4 May 2026 | Human Drugs | On file |
| Wells Pharma of Houston LLC | 13 Apr 2026 | Human Drugs | On file |
| Biomedical Research Foundation of Northwest Louisiana | 20 Feb 2026 | Human Drugs | On file |
| Biomedical Research Foundation of Northwest Louisiana | 20 Feb 2026 | Human Drugs | On file |
| Iso-Tex Diagnostics, Inc. | 3 Feb 2026 | Human Drugs | On file |
Sites inspected
QuVa Pharma, Inc.Sugar Land, United States1 insp.
Wells Pharma of Houston LLCHouston, United States1 insp.
Biomedical Research Foundation of Northwest LouisianaShreveport, United States1 insp.
Biomedical Research Foundation of Northwest LouisianaShreveport, United States1 insp.
Iso-Tex Diagnostics, Inc.Alvin, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Jason R Caballero5 shared
Demario L Walls3 shared
Tamara S Rosbury3 shared
Oluwasefunm Agbanigo2 shared
Rodney L Tinzie2 shared
Brittny C Cargo2 shared
Christopher N Tran2 shared
Stacey S Degarmo2 shared
Jonathan G Matrisciano2 shared
Alice C Silva2 shared
Full investigator report
Get the verbatim findings behind Camerson E Moore's 768 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site